Cargando…
Upadacitinib-induced paradoxical face and scalp dermatitis: A case report of a novel sequela
Atopic dermatitis is a chronic, pruritic inflammatory cutaneous condition that can carry significant morbidity. Severe or recalcitrant atopic dermatitis is often treated with immunosuppressants, biologics, or immune-modulating small molecule therapies. The Janus kinase–signal transducer and activato...
Autores principales: | Pastukhova, Elena, Spurr, Alison, Nakonechny, Quentin, Lipson, Jennifer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108407/ https://www.ncbi.nlm.nih.gov/pubmed/37077807 http://dx.doi.org/10.1177/2050313X231164271 |
Ejemplares similares
-
Pityriasis rubra pilaris partially responsive to treatment with upadacitinib: A case report
por: Saad, Mysa, et al.
Publicado: (2023) -
Atopic dermatitis treated with tralokinumab and upadacitinib combination therapy: A case report
por: Lansang, Rafael Paolo, et al.
Publicado: (2023) -
Upadacitinib for the treatment of alopecia areata and severe atopic dermatitis in a paediatric patient: A case report
por: Bourkas, Adrienn N, et al.
Publicado: (2022) -
Segmental infantile hemangioma with milia: A case report
por: Pastukhova, Elena, et al.
Publicado: (2023) -
Segmental Darier’s disease: A case report
por: Pastukhova, Elena, et al.
Publicado: (2023)